[1]
“Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients”, jrenhep, vol. 4, no. 1, pp. 22–30, May 2020, doi: 10.15586/jrenhep.2020.61.